0001213900-21-013185.txt : 20210303
0001213900-21-013185.hdr.sgml : 20210303
20210303163047
ACCESSION NUMBER: 0001213900-21-013185
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210226
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woody James N.
CENTRAL INDEX KEY: 0001553355
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 21709422
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 WEST 56TH STREET SUITE 5901
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-319-5555
MAIL ADDRESS:
STREET 1: 150 WEST 56TH STREET SUITE 5901
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
X0306
4
2021-02-26
0
0001690080
180 Life Sciences Corp.
ATNF
0001553355
Woody James N.
830 MENLO AVENUE, SUITE 100
MENLO PARK
CA
94025
1
1
0
0
Chief Executive Officer
Common Stock
25252
D
Stock Option (Right to Buy)
4.43
2021-02-26
4
A
0
1400000
0.00
A
2031-02-26
Common Stock
1400000
1400000
D
The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as Chief Executive Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.
The options vest at the rate of (a) 1/5th of such options on the grant date; and (b) 4/5th of such options vesting ratably on a monthly basis over the following 36 months on the last day of each calendar month, subject to the Reporting Person's continued service to the Company on such vesting dates.
/s/ James N. Woody
2021-03-03